John F Ginascol, Executive Vice President

ABT 66,445 shares

The estimated Net Worth of John F Ginascol is at least $5,154,803.10. John F Ginascol owns over 66,445 units of Abbott Laboratories stock worth over $5,154,803.10.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
3rd June 2019ABT - Abbott Laboratories11,967Grant/award etc.60,584$0.00
21st February 2020ABT - Abbott Laboratories18,855Grant/award etc.75,297$0.00
2nd March 2020ABT - Abbott Laboratories5,600Open or private sale66,445$77.58$434,448.00$5,154,803.10
2nd March 2020ABT - Abbott Laboratories1,006Open or private sale72,045$77.89$78,357.34$5,611,585.05
28th February 2020ABT - Abbott Laboratories2,246Payment by withholding73,051$79.19$177,860.74$5,784,908.69
21st April 2020ABT - Abbott Laboratories39,234Open or private sale66,445$96.26$3,776,629.53$6,395,935.90
21st April 2020ABT - Abbott Laboratories23,966Open or private sale105,679$95.57$2,290,421.03$10,099,699.76
21st April 2020ABT - Abbott Laboratories63,200Exercise of derivative129,645$38.40$2,426,880.00$4,978,368.00
3rd June 2020ABT - Abbott Laboratories1,768Payment by withholding64,677$92.62$163,752.16$5,990,383.74
1st September 2020ABT - Abbott Laboratories47,772Payment by withholding89,003$109.47$5,229,600.84$9,743,158.41
1st September 2020ABT - Abbott Laboratories39,953Exercise of derivative136,775$44.40$1,773,913.20$6,072,810.00
1st September 2020ABT - Abbott Laboratories20,133Exercise of derivative96,822$38.40$773,107.20$3,717,964.80
1st September 2020ABT - Abbott Laboratories12,012Exercise of derivative76,689$47.00$564,564.00$3,604,383.00